Governance Pacira BioSciences, Inc.

PCRX

US6951271005

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-05 pm EST			5-day change	1st Jan Change
23.99 ^USD	+0.04%		+1.78%	+27.34%

Dec. 03	Pacira Biosciences reports inducement grants under Nasdaq Listing Rule	RE
Dec. 02	Pacira Says Iovera Outperformed Radiofrequency Ablation in Chronic Low Back Pain	MT

Executive Committee: Pacira BioSciences, Inc.

Manager

Positions heldSince

Frank Lee

57 year

Chief Executive Officer

2024-01-01

Shawn Cross

57 year

Director of Finance/CFO

2024-10-20

Lauren Riker

46 year

Comptroller/Controller/Auditor

2012-03-20

Anthony Molloy

51 year

Compliance Officer	-
General Counsel	-

Jonathan Slonin

50 year

Chief Tech/Sci/R&D Officer

2021-06-30

Susan Mesco

Investor Relations Contact

2015-03-31

Kristen Williams

51 year

Chief Administrative Officer	2014-09-30
General Counsel	2011-11-30
Corporate Secretary	2014-09-30

Composition of the Board of Directors: Pacira BioSciences, Inc.

Director

CommitteesSince

Laura Brege

67 year

Audit Committee Chair	2011-05-31
Governance Committee	2019-07-16
Nominating Committee	2019-07-16
Compensation Committee	2020-11-30

Alethia Young

46 year

Audit Committee
Governance Committee	2022-06-08
Nominating Committee	2022-06-08
Audit Committee Chair	2025-01-29

Mark Kronenfeld

70 year

Compensation Committee	2013-09-12
Governance Committee Chair	2013-06-11
Nominating Committee Chair	2013-06-11

Christopher Christie

62 year

Governance Committee	2019-09-17
Nominating Committee	2019-09-17

Abraham Ceesay

47 year

Audit Committee	2025-01-27
Compensation Committee	2023-10-09

Mark Froimson

64 year

Audit Committee

2017-06-14

Michael Yang

63 year

Compensation Committee Chair

2023-10-09

Frank Lee

57 year

Compensation Committee

2024-05-13

Marcelo Bigal

55 year

Director/Board Member	2023-10-09
Independent Dir/Board Member	2023-10-09

Latest Appointments: Pacira BioSciences, Inc.

Mar. 14	DOMA Perpetual Nominates Candidates for the Board of Pacira BioSciences	CI
Jan. 30	Pacira BioSciences, Inc. Announces Board and Audit Committee Changes	CI
Jan. 21	Pacira BioSciences, Inc. Announces Appointment of Brendan Teehan as Chief Commercial Officer and Krys Corbett as Chief Business Officer	CI
24-10-21	Pacira Biosciences Names Shawn Cross CFO	MT
24-10-21	Pacira BioSciences, Inc. Announces Chief Financial Officer Changes	CI
24-09-27	Pacira BioSciences, Inc. Appoints Lauren Riker as Interim Chief Financial Officer, Effective October 1, 2024	CI
24-09-09	Pacira Biosciences, Inc. Announces Board Changes	CI

More news

Former Officers and Directors: Pacira BioSciences, Inc.

Insider

Positions held

SinceUntil

Andreas Wicki

Director/Board Member	2006-11-30	2025-01-27
Independent Dir/Board Member	2006-11-30	2025-01-27

Paul Hastings

Director/Board Member	2011-06-01	2024-01-01
Chairman	2024-01-01	2025-01-27
Independent Dir/Board Member	2011-06-01	2024-01-01

Charles Reinhart

Director of Finance/CFO

2016-04-30

2024-09-29

Gary Pace

Director/Board Member	2008-05-31	2024-06-29
Independent Dir/Board Member	2008-05-31	2024-06-29

David Stack

Director/Board Member	2010-11-02	2013-07-11
Chief Executive Officer	2007-10-31	2023-12-31
Chairman	2013-07-11	2023-12-31
Chief Operating Officer	2018-03-26	2022-05-03
President	2007-10-31	2015-10-19

Richard Kahr

Human Resources Officer

2015-01-31

2023-11-30

Charles Laranjeira

Chief Tech/Sci/R&D Officer

2017-04-30

2023-05-31

Yvonne Greenstreet

Director/Board Member	2014-03-03	2023-03-30
Independent Dir/Board Member	2014-03-03	2023-03-30

Donald C. Manning

Chief Tech/Sci/R&D Officer

2020-05-03

2021-06-15

Mary Pietryga

Corporate Officer/Principal

2019-03-31

2021-02-28

Vladimir Kharitonov

Chief Tech/Sci/R&D Officer	2012-05-23	2020-07-31
Corporate Officer/Principal	2010-11-02	2012-05-23

Richard Scranton

Chief Tech/Sci/R&D Officer	2017-05-31	2020-01-23
Corporate Officer/Principal	-	2017-12-06

Max Reinhardt

Corporate Officer/Principal	2020-06-08	-
President	2019-06-18	2020-06-08

Dennis Winger

Director/Board Member	2013-09-10	2018-06-11
Independent Dir/Board Member	2013-09-10	2018-06-11

Scott Braunstein

Chief Operating Officer	2017-12-10	2018-03-26
Corporate Officer/Principal	2015-07-13	2017-12-10

James Scibetta

Director of Finance/CFO	2008-07-31	2016-05-02
President	2015-10-19	2017-06-29

Harry Kovelman

Chief Tech/Sci/R&D Officer

2013-12-31

2016-12-31

Roy Winston

Chief Tech/Sci/R&D Officer	2018-07-31	-
Corporate Officer/Principal	2016-12-31	2018-07-31

Thomas Sluby

Sales & Marketing

2016-10-19

2016-12-31

Sergio Alegre

Director/Board Member

2012-07-31

2016-07-31

Robert J. Weiland

Corporate Officer/Principal

2016-03-31

Taunia S. Markvicka

Corporate Officer/Principal

2007-12-31

2016-01-06

Vinay Shah

Corporate Officer/Principal

2007-12-31

2015-12-31

Gary Patou

Chief Tech/Sci/R&D Officer

2010-11-02

2015-08-18

James B. Jones

Chief Tech/Sci/R&D Officer

2015-08-16

Dennis Mcloughlin

Corporate Officer/Principal

2018-07-31

Fred Middleton

Director/Board Member

2013-07-11

2013-09-29

Luke Evnin

Director/Board Member	2006-11-30	2013-09-29
Independent Dir/Board Member	2011-05-25	2013-09-29

Tim M. Ciaccio

Chief Tech/Sci/R&D Officer

2012-07-31

Paul R. Ellwood

Human Resources Officer

2012-04-30

Mark Walters

Chief Tech/Sci/R&D Officer	2011-12-26	2011-12-31
Corporate Officer/Principal	2009-10-20	2011-12-26

William J. Lambert

Corporate Officer/Principal

2010-11-02

2011-09-29

Carl Gordon

Director/Board Member	2009-10-20	2011-06-02
Independent Dir/Board Member	2011-05-25	2011-06-02

David St. Peter

Corporate Officer/Principal

2008-09-30

2009-05-31

Fred M. Ryan

Corporate Officer/Principal

2009-10-20

John P. Longenecker

Director/Board Member	2007-06-30	-
Independent Dir/Board Member	2007-06-30	-

Lynette M. Bowman

Human Resources Officer

2010-11-02

Jessica Cho

Investor Relations Contact

David Kaplan

Sales & Marketing

Doug Silveira

Corporate Officer/Principal

Admir Hadzic

Corporate Officer/Principal

Ronald M. Burch

Chief Tech/Sci/R&D Officer

2009-10-20

Ron Ellis

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	13
Female	6

Of which Executive Committee

Male	4
Female	3

Of which Directors

Male	7
Female	2

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Pacira BioSciences, Inc. is a holding company for Pacira Pharmaceuticals, Inc. The Company's non-opioid treatments include EXPAREL (bupivacaine liposome injectable suspension), which is a long-acting, local analgesic for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), which is an extended-release, intra-articular (IA), corticosteroid injection indicated for OA knee pain, and Iovera, which is a novel handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. EXPAREL is used across multiple orthopedic procedures, including joint reconstruction, shoulder, spine, extremity procedures, and hip fractures. It is developing interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain. Its clinical development programs include PCRX-201, and pMVL-Based Clinical Program.

Employees

789

Sector

Pharmaceuticals

Calendar

Feb. 18 - Q4 2025 Earnings Release (Projected)

More about the company